{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:51:34Z","timestamp":1791323494134,"version":"4.3.1"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Government Ministry of Health","doi-asserted-by":"publisher","award":["GR-2019-12371442"],"award-info":[{"award-number":["GR-2019-12371442"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymthe.2026.09.023","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:00:31Z","timestamp":1790060431000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted epigenetic reactivation strategies as new treatments for Prader-Willi syndrome: Achievements and challenges"],"prefix":"10.1016","author":[{"given":"Simone","family":"Alberti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Cutei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Costa Broccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vania","family":"Broccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0954-7822","authenticated-orcid":false,"given":"Gaia","family":"Colasante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.09.023_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/ejhg.2011.187","article-title":"Unique and atypical deletions in Prader-Willi syndrome reveal distinct phenotypes","volume":"20","author":"Kim","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2026.09.023_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","article-title":"Prader-Willi syndrome","volume":"14","author":"Cassidy","year":"2012","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymthe.2026.09.023_bib3","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/ajmg.a.32364","article-title":"Mechanisms of imprinting of the Prader-Willi\/Angelman region","volume":"146A","author":"Horsthemke","year":"2008","journal-title":"Am. J. Med. Genet. A."},{"key":"10.1016\/j.ymthe.2026.09.023_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1573396315666190716120925","article-title":"Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update","volume":"15","author":"Butler","year":"2019","journal-title":"Curr. Pediatr. Rev."},{"key":"10.1016\/j.ymthe.2026.09.023_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mce.2011.02.011","article-title":"Ghrelin in obesity and endocrine diseases","volume":"340","author":"Scerif","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ymthe.2026.09.023_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajmg.a.30777","article-title":"Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment","volume":"136","author":"Nagai","year":"2005","journal-title":"Am. J. Med. Genet. A."},{"key":"10.1016\/j.ymthe.2026.09.023_bib7","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1210\/jc.2009-1389","article-title":"Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome","volume":"95","author":"Carrel","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymthe.2026.09.023_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/genes14010097","article-title":"Analysis of SNHG14: A Long Non-Coding RNA Hosting SNORD116, Whose Loss Contributes to Prader\u2013Willi Syndrome Etiology","volume":"14","author":"Ariyanfar","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.ymthe.2026.09.023_bib9","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1073\/pnas.1411261111","article-title":"Angelman syndrome imprinting center encodes a transcriptional promoter","volume":"112","author":"Lewis","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.09.023_bib10","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1530\/EJE-20-0103","article-title":"GENETICS IN ENDOCRINOLOGY: Genetic etiologies of central precocious puberty and the role of imprinted genes","volume":"183","author":"Roberts","year":"2020","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ymthe.2026.09.023_bib11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fendo.2019.00048","article-title":"MKRN3 Interacts With Several Proteins Implicated in Puberty Timing but Does Not Influence GNRH1 Expression","volume":"10","author":"Yellapragada","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ymthe.2026.09.023_bib12","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20220610","article-title":"Proteins and proteases of Prader\u2013Willi syndrome: a comprehensive review and perspectives","volume":"42","author":"Basak","year":"2022","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ymthe.2026.09.023_bib13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/gbe\/evu019","article-title":"The imprinted NPAP1 gene in the Prader-Willi syndrome region belongs to a POM121-related family of retrogenes","volume":"6","author":"Neumann","year":"2014","journal-title":"Genome Biol. Evol."},{"key":"10.1016\/j.ymthe.2026.09.023_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.yfrne.2013.01.002","article-title":"Mouse models of Prader\u2013Willi Syndrome: A systematic review","volume":"34","author":"Bervini","year":"2013","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.ymthe.2026.09.023_bib16","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/cge.13005","article-title":"SNORD116 deletions cause Prader-Willi syndrome with a mild phenotype and macrocephaly","volume":"92","author":"Fontana","year":"2017","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymthe.2026.09.023_bib17","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1073\/pnas.1815279116","article-title":"A bipartite boundary element restricts UBE3A imprinting to mature neurons","volume":"116","author":"Hsiao","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.09.023_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004039","article-title":"Truncation of Ube3a-ATS Unsilences Paternal Ube3a and Ameliorates Behavioral Defects in the Angelman Syndrome Mouse Model","volume":"9","author":"Meng","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ymthe.2026.09.023_bib19","article-title":"Phylogenetic and Molecular Analyses Identify SNORD116 Targets Involved in the Prader\u2013Willi Syndrome","volume":"39","author":"Baldini","year":"2021","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.ymthe.2026.09.023_bib20","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1469-7610.2005.01520.x","article-title":"Prader-Willi syndrome: intellectual abilities and behavioural features by genetic subtype","volume":"46","author":"Milner","year":"2005","journal-title":"Child Psychol. Psychiatry"},{"key":"10.1016\/j.ymthe.2026.09.023_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0140-6736(02)07340-3","article-title":"Psychotic illness in people with Prader Willi syndrome due to chromosome 15 maternal uniparental disomy","volume":"359","author":"Boer","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2026.09.023_bib22","series-title":"Prader-Willi Syndrome: Development and Manifestations","author":"Whittington","year":"2004"},{"key":"10.1016\/j.ymthe.2026.09.023_bib23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2788.2001.00326.x","article-title":"Kinetic form discrimination in Prader\u2013Willi syndrome","volume":"45","author":"Fox","year":"2001","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.ymthe.2026.09.023_bib24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00787-004-0354-6","article-title":"Prader-Willi syndrome--a study comparing deletion and uniparental disomy cases with reference to autism spectrum disorders","volume":"13","author":"Veltman","year":"2004","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.ymthe.2026.09.023_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00041444-200512000-00006","article-title":"Autism spectrum disorders in Prader-Willi and Angelman syndromes: a systematic review","volume":"15","author":"Veltman","year":"2005","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.ymthe.2026.09.023_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002422","article-title":"Transcription Is Required to Establish Maternal Imprinting at the Prader-Willi Syndrome and Angelman Syndrome Locus","volume":"7","author":"Smith","year":"2011","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ymthe.2026.09.023_bib27","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1086\/324469","article-title":"Parent-specific complementary patterns of histone H3 lysine 9 and H3 lysine 4 methylation at the Prader-Willi syndrome imprinting center","volume":"69","author":"Xin","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2026.09.023_bib28","doi-asserted-by":"crossref","first-page":"14996","DOI":"10.1074\/jbc.M211753200","article-title":"Role of Histone Methyltransferase G9a in CpG Methylation of the Prader-Willi Syndrome Imprinting Center","volume":"278","author":"Xin","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.09.023_bib29","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1038\/s41467-025-61156-8","article-title":"Mechanism of EHMT2-mediated genomic imprinting associated with Prader-Willi syndrome","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.09.023_bib30","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1093\/hmg\/ddu187","article-title":"Reactivation of maternal SNORD116 cluster via SETDB1 knockdown in Prader-Willi syndrome iPSCs","volume":"23","author":"Cruvinel","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.09.023_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015082","article-title":"ZNF274 Recruits the Histone Methyltransferase SETDB1 to the 3\u2032 Ends of ZNF Genes","volume":"5","author":"Frietze","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.09.023_bib32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/hmg\/ddx420","article-title":"Zinc finger protein 274 regulates imprinted expression of transcripts in Prader-Willi syndrome neurons","volume":"27","author":"Langou\u00ebt","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.09.023_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/hmg\/8.2.337","article-title":"The chromosome 15 imprinting centre (IC) region has undergone multiple duplication events and contains an upstream exon of SNRPN that is deleted in all Angelman syndrome patients with an IC microdeletion","volume":"8","author":"F\u00e4rber","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.09.023_bib34","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1093\/hmg\/ddaa210","article-title":"Specific ZNF274 binding interference at SNORD116 activates the maternal transcripts in Prader-Willi syndrome neurons","volume":"29","author":"Langou\u00ebt","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.09.023_bib35","series-title":"What Are the Treatments for Prader-Willi Syndrome (PWS)?","year":"2021"},{"key":"10.1016\/j.ymthe.2026.09.023_bib36","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1086\/302917","article-title":"Parent-of-Origin Specific Histone Acetylation and Reactivation of a Key Imprinted Gene Locus in Prader-Willi Syndrome","volume":"66","author":"Saitoh","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2026.09.023_bib37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm.4257","article-title":"Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader\u2013Willi syndrome","volume":"23","author":"Kim","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.09.023_bib38","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/j.ymthe.2024.05.034","article-title":"Newly developed oral bioavailable EHMT2 inhibitor as a potential epigenetic therapy for Prader-Willi syndrome","volume":"32","author":"Wang","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.09.023_bib39","article-title":"Activation of the imprinted Prader-Willi syndrome locus by CRISPR-based epigenome editing","volume":"5","author":"Rohm","year":"2025","journal-title":"Cell Genom."},{"key":"10.1016\/j.ymthe.2026.09.023_bib40","doi-asserted-by":"crossref","first-page":"9442","DOI":"10.1038\/s41467-025-64932-8","article-title":"Rescue of imprinted genes by epigenome editing in human cellular models of Prader-Willi syndrome","volume":"16","author":"Nemoto","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.09.023_bib41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/hmg\/7.1.109","article-title":"In Vitro Reactivation of the FMR1 Gene Involved in Fragile X Syndrome","volume":"7","author":"Chiurazzi","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.09.023_bib42","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/hmg\/10.6.645","article-title":"Association of acetylated histones with paternally expressed genes in the Prader--Willi deletion region","volume":"10","author":"Fulmer-Smentek","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.09.023_bib43","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1523\/JNEUROSCI.3796-07.2008","article-title":"Activity-Dependent Suppression of Miniature Neurotransmission through the Regulation of DNA Methylation","volume":"28","author":"Nelson","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2026.09.023_bib44","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1590\/1414-431X20144058","article-title":"Stability of XIST repression in relation to genomic imprinting following global genome demethylation in a human cell line","volume":"47","author":"de Ara\u00fajo","year":"2014","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.ymthe.2026.09.023_bib45","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1101\/gad.1452206","article-title":"Deficiency of Rbbp1\/Arid4a and Rbbp1l1\/Arid4b alters epigenetic modifications and suppresses an imprinting defect in the PWS\/AS domain","volume":"20","author":"Wu","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymthe.2026.09.023_bib46","doi-asserted-by":"crossref","first-page":"8931","DOI":"10.1021\/jm401480r","article-title":"Discovery of an in vivo chemical probe of the lysine methyltransferases G9a and GLP","volume":"56","author":"Liu","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ymthe.2026.09.023_bib47","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nchembio.599","article-title":"A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells","volume":"7","author":"Vedadi","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ymthe.2026.09.023_bib48","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/hmg\/8.8.1357","article-title":"Paternal deletion from Snrpn to Ube3a in the mouse causes hypotonia, growth retardation and partial lethality and provides evidence for a gene contributing to Prader-Willi syndrome","volume":"8","author":"Tsai","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.09.023_bib49","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ajmg.b.32022","article-title":"The Neuroanatomy of Genetic Subtype Differences in Prader-Willi Syndrome","volume":"159B","author":"Honea","year":"2012","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymthe.2026.09.023_bib50","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.09.023_bib51","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1172\/JCI80554","article-title":"Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model","volume":"125","author":"Silva-Santos","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.09.023_bib52","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature16971","article-title":"Adult restoration of Shank3 expression rescues selective autistic-like phenotypes","volume":"530","author":"Y","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.09.023_bib53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41467-021-27837-w","article-title":"Scn1a gene reactivation after symptom onset rescues pathological phenotypes in a mouse model of Dravet syndrome","volume":"13","author":"Valassina","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.09.023_bib54","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41586-025-09522-w","article-title":"CRISPR activation for SCN2A-related neurodevelopmental disorders","volume":"646","author":"Tamura","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.09.023_bib55","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nmeth.2598","article-title":"CRISPR RNA-guided activation of endogenous human genes","volume":"10","author":"Maeder","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2026.09.023_bib56","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","article-title":"Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression","volume":"152","author":"Qi","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.09.023_bib57","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","article-title":"CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes","volume":"154","author":"Gilbert","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.09.023_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau0629","article-title":"CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency","volume":"363","author":"Matharu","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.09.023_bib59","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymthe.2019.08.018","article-title":"dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice","volume":"28","author":"Colasante","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.09.023_bib60","article-title":"Enhancer-targeted CRISPR-Activation Rescues Haploinsufficient Autism Susceptibility Genes","author":"Chen","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2026.09.023_bib61","doi-asserted-by":"crossref","DOI":"10.1093\/narmme\/ugaf011","article-title":"A modular CRISPRa system for molecular therapy of FOXG1 syndrome","volume":"2","author":"Halmai","year":"2025","journal-title":"NAR Mol. Med."},{"key":"10.1016\/j.ymthe.2026.09.023_bib62","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nbt.3199","article-title":"Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers","volume":"33","author":"Hilton","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.09.023_bib63","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cell.2016.08.056","article-title":"Editing DNA Methylation in the Mammalian Genome","volume":"167","author":"Liu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.09.023_bib64","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nbt.3658","article-title":"Targeted DNA demethylation in vivo using dCas9-peptide repeat and scFv-TET1 catalytic domain fusions","volume":"34","author":"Morita","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.09.023_bib65","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2014.09.039","article-title":"A protein-tagging system for signal amplification in gene expression and fluorescence imaging","volume":"159","author":"Tanenbaum","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.09.023_bib66","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature13975","article-title":"Towards a therapy for Angelman syndrome by targeting a long non-coding RNA","volume":"518","author":"Meng","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.09.023_bib67","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3390\/ijms21051574","article-title":"Synergistic Upregulation of Target Genes by TET1 and VP64 in the dCas9-SunTag Platform","volume":"21","author":"Morita","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.09.023_bib68","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf851","article-title":"Angelman syndrome patient-derived neuron screen leads to clinical ASO rugonersen targeting UBE3A-ATS with long-lasting effect in monkeys","volume":"53","author":"Jagasia","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.09.023_bib69","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1038\/s41591-025-03784-7","article-title":"The UBE3A-ATS antisense oligonucleotide rugonersen in children with Angelman syndrome: a phase 1 trial","volume":"31","author":"Hipp","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.09.023_bib70","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.3390\/ijms22073613","article-title":"A Comprehensive Review of Genetically Engineered Mouse Models for Prader-Willi Syndrome Research","volume":"22","author":"Kummerfeld","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.09.023_bib71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0598-25","article-title":"A mouse model for Prader-Willi syndrome imprinting-centre mutations","volume":"19","author":"Yang","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2026.09.023_bib72","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/90067","article-title":"The SNRPN promoter is not required for genomic imprinting of the Prader-Willi\/Angelman domain in mice","volume":"28","author":"Bressler","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2026.09.023_bib73","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1093\/hmg\/ddr262","article-title":"A new deletion refines the boundaries of the murine Prader\u2013Willi syndrome imprinting center","volume":"20","author":"DuBose","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.09.023_bib74","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/ng.158","article-title":"Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C\/D box small nucleolar RNA cluster","volume":"40","author":"Sahoo","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2026.09.023_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.0030235","article-title":"Deletion of the MBII-85 snoRNA gene cluster in mice results in postnatal growth retardation","volume":"3","author":"Skryabin","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ymthe.2026.09.023_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001709","article-title":"SnoRNA Snord116 (Pwcr1\/MBII-85) deletion causes growth deficiency and hyperphagia in mice","volume":"3","author":"Ding","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.09.023_bib77","doi-asserted-by":"crossref","first-page":"9258","DOI":"10.1073\/pnas.96.16.9258","article-title":"A transgene insertion creating a heritable chromosome deletion mouse model of Prader-Willi and angelman syndromes","volume":"96","author":"Gabriel","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.09.023_bib78","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/ng1292-270","article-title":"A candidate mouse model for Prader-Willi syndrome which shows an absence of Snrpn expression","volume":"2","author":"Cattanach","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2026.09.023_bib79","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019448","article-title":"Induced Pluripotency and Epigenetic Reprogramming","volume":"7","author":"Hochedlinger","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ymthe.2026.09.023_bib80","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.stem.2021.04.006","article-title":"Generation of hypothalamic arcuate organoids from human induced pluripotent stem cells","volume":"28","author":"Huang","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2026.09.023_bib81","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00787-020-01568-7","article-title":"A pro-inflammatory phenotype is associated with behavioural traits in children with Prader\u2013Willi syndrome","volume":"30","author":"Krefft","year":"2020","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.ymthe.2026.09.023_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102457","article-title":"Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group","volume":"36","author":"Cavazza","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.09.023_bib83","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuron.2019.02.017","article-title":"Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality","volume":"101","author":"Hudry","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2026.09.023_bib85","author":"de los Reyes"},{"key":"10.1016\/j.ymthe.2026.09.023_bib89","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1089\/hum.2020.301","article-title":"Intracerebroventricular Administration of AAV9-PHP.B SYN1-EmGFP Induces Widespread Transgene Expression in the Mouse and Monkey Central Nervous System","volume":"32","author":"Galvan","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.09.023_bib92","author":"Bankiewicz"},{"key":"10.1016\/j.ymthe.2026.09.023_bib95","author":"Biosciences"},{"key":"10.1016\/j.ymthe.2026.09.023_bib96","author":"Biosciences"},{"key":"10.1016\/j.ymthe.2026.09.023_bib97","author":"Biosciences"},{"key":"10.1016\/j.ymthe.2026.09.023_bib98","author":"Muramatsu"},{"key":"10.1016\/j.ymthe.2026.09.023_bib99","author":"Therapeutics"},{"key":"10.1016\/j.ymthe.2026.09.023_bib104","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.09.023_bib105","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.adm8386","article-title":"An AAV capsid reprogrammed to bind human transferrin receptor mediates brain-wide gene delivery","volume":"384","author":"Huang","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.09.023_bib106","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1016\/j.ymthe.2025.04.046","article-title":"Highly conserved brain vascular receptor ALPL mediates transport of engineered AAV vectors across the blood-brain barrier","volume":"33","author":"Moyer","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.09.023_bib107","series-title":"Advancing CNS Gene Therapies with Manufacturable AAV Capsids and an FDA-Integrated Regulatory Approach","author":"Santiago-Ortiz","year":"2026"},{"key":"10.1016\/j.ymthe.2026.09.023_bib108","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-65964-w","article-title":"Prime editing of the \u03b21 adrenoceptor in the brain restores physiological REM sleep in a mouse model of Alzheimer\u2019s disease","volume":"16","author":"B\u00f6ck","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.09.023_bib109","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1093\/nar\/gkv601","article-title":"Development of an intein-mediated split-Cas9 system for gene therapy","volume":"43","author":"Truong","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.09.023_bib110","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.omtn.2021.08.025","article-title":"Replacing the SpCas9 HNH domain by deaminases generates compact base editors with an alternative targeting scope","volume":"26","author":"Villiger","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.09.023_bib111","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1016\/j.molcel.2021.08.008","article-title":"Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing","volume":"81","author":"Xu","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2026.09.023_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102786","article-title":"CRISPR-Cas editing technologies for viral-mediated gene therapies of human diseases: Mechanisms, progress, and challenges","volume":"37","author":"Kantor","year":"2026","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.09.023_bib113","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","article-title":"In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates","volume":"593","author":"Musunuru","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.09.023_bib114","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41587-021-00933-4","article-title":"In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels","volume":"39","author":"Rothgangl","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.09.023_bib115","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/s41587-023-02078-y","article-title":"Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo","volume":"42","author":"An","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.09.023_bib116","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","article-title":"Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins","volume":"185","author":"Banskota","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.09.023_bib117","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/gt.2016.27","article-title":"Lentivirus pre-packed with Cas9 protein for safer gene editing","volume":"23","author":"Choi","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.09.023_bib118","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1101\/gr.171322.113","article-title":"Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins","volume":"24","author":"Kim","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.ymthe.2026.09.023_bib119","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ymthe.2020.04.017","article-title":"AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9","volume":"28","author":"Li","year":"2020","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626007938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626007938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:12:13Z","timestamp":1791321133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626007938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":106,"alternative-id":["S1525001626007938"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.09.023","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted epigenetic reactivation strategies as new treatments for Prader-Willi syndrome: Achievements and challenges","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}